Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frantz Foissac

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|September 27, 2025
Prediction of Maternal and Fetal Exposure to Escitalopram, Sertraline, and Paroxetine by Combining Human Ex Vivo Placenta Perfusion Data and Physiologically Based Pharmacokinetic ModelingLaure-Hélène Préta, Naïm Bouazza, Frantz Foissac, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 1, 2020
HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasmaYi Zheng, Radia Aboura, Sana Boujaafar, et al.
Fundamental & Clinical Pharmacology|October 19, 2019
Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditionsOlivier Mangin, Yi Zheng, Naïm Bouazza, et al.
Antiviral Therapy|October 4, 2014
Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinationsNaïm Bouazza, Frantz Foissac, Floris Fauchet, et al.
British Journal of Clinical Pharmacology|May 27, 2015
Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant womenMaïlys De Sousa Mendes, Deborah Hirt, Saik Urien, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 11, 2021
Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MSYi Zheng, Gabrielle Lui, Sana Boujaafar, et al.
British Journal of Clinical Pharmacology|July 22, 2014
Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?Floris Fauchet, Jean-Marc Treluyer, Elodie Valade, et al.
Journal of Clinical Pharmacology|February 28, 2015
Prediction of drug clearance in childrenFrantz Foissac, Naïm Bouazza, Elodie Valade, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Population pharmacokinetics of emtricitabine in HIV-1-infected adult patientsElodie Valade, Jean-Marc Tréluyer, Naïm Bouazza, et al.
British Journal of Clinical Pharmacology|January 3, 2013
Evaluation of nevirapine dosing recommendations in HIV-infected childrenFrantz Foissac, Naïm Bouazza, Pierre Frange, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|September 27, 2025
Prediction of Maternal and Fetal Exposure to Escitalopram, Sertraline, and Paroxetine by Combining Human Ex Vivo Placenta Perfusion Data and Physiologically Based Pharmacokinetic ModelingLaure-Hélène Préta, Naïm Bouazza, Frantz Foissac, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 1, 2020
HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasmaYi Zheng, Radia Aboura, Sana Boujaafar, et al.
Fundamental & Clinical Pharmacology|October 19, 2019
Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditionsOlivier Mangin, Yi Zheng, Naïm Bouazza, et al.
Antiviral Therapy|October 4, 2014
Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinationsNaïm Bouazza, Frantz Foissac, Floris Fauchet, et al.
British Journal of Clinical Pharmacology|May 27, 2015
Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant womenMaïlys De Sousa Mendes, Deborah Hirt, Saik Urien, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 11, 2021
Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MSYi Zheng, Gabrielle Lui, Sana Boujaafar, et al.
British Journal of Clinical Pharmacology|July 22, 2014
Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?Floris Fauchet, Jean-Marc Treluyer, Elodie Valade, et al.
Journal of Clinical Pharmacology|February 28, 2015
Prediction of drug clearance in childrenFrantz Foissac, Naïm Bouazza, Elodie Valade, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Population pharmacokinetics of emtricitabine in HIV-1-infected adult patientsElodie Valade, Jean-Marc Tréluyer, Naïm Bouazza, et al.
British Journal of Clinical Pharmacology|January 3, 2013
Evaluation of nevirapine dosing recommendations in HIV-infected childrenFrantz Foissac, Naïm Bouazza, Pierre Frange, et al.
Pageof 8